FDA Panel Says Some Asthma Inhalers are Risky and are not Worth Taking.
A FDA Panel said Thursday that the risks of death and serious injury associated with certain of asthma inhalers are greater than the benefits of the drugs. The drugs discussed by panel were: Serevent, Advair, Foradil, and Symbicort.
Asthma is a chronic condition which affects about 22 million Americans, including 6.5 million children and is marked by narrowing of the airways, which causes sudden difficulty breathing. The inhalers are known as long-acting beta-agonists, or LABAs, and are designed to reduce tightening of the muscles around the airway caused by asthma.
It is estimated that six million asthma patients have been prescribed these types of medications. The FDA asked the panel expert panel for advice on whether to allow certain drugs to continue to be marketed for the treatment of asthma in children and adults. There have been concerns that the products increase the risk of asthma-related side effects.
Read more.............. http://askcrazy.com/
Justin Kodua Launches Bid to Retain NPP General Secretary Post Ahead of Crucial ...
Zanetor Demands Continental Action: ‘Africa Cannot Progress While Women Live in ...
Mahama assures transfer of UGMC to University of Ghana
Wontumi told me he would get 20year jail term before judgment was read – Lawyer ...
Sarkodie Warns Gov’t: ‘Explain the 24-Hour Economy or Risk Voter Backlash’
‘Ofori-Atta Must Account’: COPEC Boss Warns NPP of 2028 Backlash Over Lingering ...
UG Economist Slams Gov’t: “24-Hour Economy Implementation Far From Reality”
Ghana Flags 1.8m Housing Gap at UN Forum, Says Urban Pressures Demand Urgent Act...
NDC Draws Red Line: Gov’t Appointees Who Don’t Resign Barred from Executive Elec...
Kpebu Warns: “Judicial Independence Won’t Come From Law Alone — It Needs Judges ...
